The mechanism(s) responsible for injury of endothelial cells induced by human leukocyte elastase (HLE) was investigated in an immortalized venous human endothelial cell line (IVEC).First, the proteinase concentrations and incubation delays necessary to trigger a significant IVEC cytotoxicity were determined by chromium assays. Thus, exposure of IVEC for 6 h to 10 μ ml−1HLE resulted in 22 ± 2.8% lysis and 36.4 ± 5.4% detachment (mean ± s.e. mean;n= 4;P< 0.05).WEB 2086, a specific platelet‐activating factor (PAF) receptor antagonist, induced a significant concentration‐dependent decrease of such a lysis (39.6 ± 7.7% protection at 100 μn= 4). This potential role for PAF was confirmed with two other antagonists of this lipid mediator, i.e., BN 52021 and RP 48740.Finally, we demonstrated that pretreatment of IVEC with WEB 2086 protected significantly against cell lysis induced by stimulated human neutrophils, an experimental model in which HLE participates.